dc.contributor.author | Koprulu, S. | |
dc.contributor.author | Cevik, I. | |
dc.contributor.author | Unlu, N. | |
dc.contributor.author | Dillioglugil, O. | |
dc.date.accessioned | 2021-12-21T08:41:57Z | |
dc.date.available | 2021-12-21T08:41:57Z | |
dc.date.issued | 2012 | |
dc.identifier.issn | 3011623 | |
dc.identifier.uri | https://doi.org/10.1007/s11255-011-9993-y | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1556 | |
dc.description.abstract | Introduction and objectives In the great majority of the cases, transrectal ultrasound guided prostate biopsy (TRUS-Bx) is the definitive step in the diagnosis of prostate cancer (CaP). Although this procedure is well tolerated by most patients, it can re | |
dc.language.iso | English | |
dc.title | Size of the transrectal ultrasound probe makes no difference in pain perception during TRUS-Bx under adequate local anesthesia | |
dc.type | Article | |
dc.relation.journal | International Urology and Nephrology | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 29 | |
dc.identifier.endpage | 33 | |
dc.identifier.volume | 44 | |
dc.identifier.doi | 10.1007/s11255-011-9993-y | |
dc.relation.issue | 1 | |
dc.relation.volume | 44 | |